These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 3180056)
1. Verapamil reversal of doxorubicin resistance in multidrug-resistant human myeloma cells and association with drug accumulation and DNA damage. Bellamy WT; Dalton WS; Kailey JM; Gleason MC; McCloskey TM; Dorr RT; Alberts DS Cancer Res; 1988 Nov; 48(22):6365-70. PubMed ID: 3180056 [TBL] [Abstract][Full Text] [Related]
2. Direct relation of DNA lesions in multidrug-resistant human myeloma cells to intracellular doxorubicin concentration. Bellamy WT; Dorr RT; Dalton WS; Alberts DS Cancer Res; 1988 Nov; 48(22):6360-4. PubMed ID: 3180055 [TBL] [Abstract][Full Text] [Related]
3. Evidence for cytoplasmic P-glycoprotein location associated with increased multidrug resistance and resistance to chemosensitizers. Abbaszadegan MR; Cress AE; Futscher BW; Bellamy WT; Dalton WS Cancer Res; 1996 Dec; 56(23):5435-42. PubMed ID: 8968098 [TBL] [Abstract][Full Text] [Related]
4. Decreased P-glycoprotein expression in multidrug-sensitive and -resistant human myeloma cells induced by the cytokine leukoregulin. Evans CH; Baker PD Cancer Res; 1992 Nov; 52(21):5893-9. PubMed ID: 1356622 [TBL] [Abstract][Full Text] [Related]
5. Severe combined immunodeficiency (SCID) mouse modeling of P-glycoprotein chemosensitization in multidrug-resistant human myeloma xenografts. Bellamy WT; Odeleye A; Huizenga E; Dalton WS; Weinstein RS; Grogan TM Clin Cancer Res; 1995 Dec; 1(12):1563-70. PubMed ID: 9815957 [TBL] [Abstract][Full Text] [Related]
6. Characterization of a new drug-resistant human myeloma cell line that expresses P-glycoprotein. Dalton WS; Durie BG; Alberts DS; Gerlach JH; Cress AE Cancer Res; 1986 Oct; 46(10):5125-30. PubMed ID: 2875788 [TBL] [Abstract][Full Text] [Related]
7. Pharmacological and biological evidence for differing mechanisms of doxorubicin resistance in two human tumor cell lines. Slovak ML; Hoeltge GA; Dalton WS; Trent JM Cancer Res; 1988 May; 48(10):2793-7. PubMed ID: 2896069 [TBL] [Abstract][Full Text] [Related]
8. Enhancement of adriamycin-induced cytotoxicity by increasing retention and inhibition of DNA repair in DOX-resistant P388 cell lines with new calcium channel blocker, DMDP. Bankusli I; Yin MB; Mazzoni A; Abdellah AJ; Rustum YM Anticancer Res; 1989; 9(3):567-74. PubMed ID: 2764503 [TBL] [Abstract][Full Text] [Related]
9. Potentiation of pirarubicin cytotoxicity by dipyridamole in doxorubicin-resistant mouse P388 leukemia cells. Furusawa S; Fujimura T; Kawauchi H; Sasaki K; Takayanagi Y Res Commun Chem Pathol Pharmacol; 1991 Mar; 71(3):321-36. PubMed ID: 2047575 [TBL] [Abstract][Full Text] [Related]
10. Verapamil-mediated sensitization of doxorubicin-selected pleiotropic resistance in human sarcoma cells: selectivity for drugs which produce DNA scission. Harker WG; Bauer D; Etiz BB; Newman RA; Sikic BI Cancer Res; 1986 May; 46(5):2369-73. PubMed ID: 3754487 [TBL] [Abstract][Full Text] [Related]
11. Multidrug resistance in a human leukemic cell line selected for resistance to trimetrexate. Arkin H; Ohnuma T; Kamen BA; Holland JF; Vallabhajosula S Cancer Res; 1989 Dec; 49(23):6556-61. PubMed ID: 2573416 [TBL] [Abstract][Full Text] [Related]
12. Cross resistance relevance of the chemical structure of different anthracyclines in multidrug resistant cells. Tapiero H; Nguyen-Ba G; Lampidis TJ Pathol Biol (Paris); 1994 Apr; 42(4):328-37. PubMed ID: 7808786 [TBL] [Abstract][Full Text] [Related]
13. Mechanisms of the in vivo resistance to adriamycin and modulation by calcium channel blockers in mice. Yin MB; Bankusli I; Rustum YM Cancer Res; 1989 Sep; 49(17):4729-33. PubMed ID: 2758408 [TBL] [Abstract][Full Text] [Related]
14. Modulation of vindesine and doxorubicin resistance in multidrug-resistant pleural mesothelioma cells by tumor necrosis factor-alpha. Licht T; Lübbert M; Martens C; Bross KJ; Fiebig HH; Mertelsmann R; Herrmann F Cytokines Mol Ther; 1995 Jun; 1(2):123-32. PubMed ID: 9384669 [TBL] [Abstract][Full Text] [Related]
15. Cytogenetic and phenotypic analysis of a human colon carcinoma cell line resistant to mitoxantrone. Dalton WS; Cress AE; Alberts DS; Trent JM Cancer Res; 1988 Apr; 48(7):1882-8. PubMed ID: 2894893 [TBL] [Abstract][Full Text] [Related]
16. Resistance to adriamycin: relationship of cytotoxicity to drug uptake and DNA single- and double-strand breakage in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia. Goldenberg GJ; Wang H; Blair GW Cancer Res; 1986 Jun; 46(6):2978-83. PubMed ID: 3698020 [TBL] [Abstract][Full Text] [Related]
17. Reversal of P-gp mediated multidrug resistance in-vitro and in-vivo by FG020318. Chen LM; Liang YJ; Ruan JW; Ding Y; Wang XW; Shi Z; Gu LQ; Yang XP; Fu LW J Pharm Pharmacol; 2004 Aug; 56(8):1061-6. PubMed ID: 15285852 [TBL] [Abstract][Full Text] [Related]
18. DNA breakage, cytotoxicity, drug accumulation and retention in two human ovarian tumor cell lines AZ224 and AZ364 treated with adriamycin, modulated by verapamil. Delvaeye M; Verovski V; De Neve W; Storme G Anticancer Res; 1993; 13(5A):1533-8. PubMed ID: 8239532 [TBL] [Abstract][Full Text] [Related]
19. Reversal of Vinca alkaloid resistance but not multiple drug resistance in human leukemic cells by verapamil. Beck WT; Cirtain MC; Look AT; Ashmun RA Cancer Res; 1986 Feb; 46(2):778-84. PubMed ID: 3455678 [TBL] [Abstract][Full Text] [Related]
20. Doxorubicin resistance circumvention by verapamil in B16 melanoma cells. Mariani M; Prosperi E; Colombo A; Supino R Anticancer Res; 1989; 9(1):29-32. PubMed ID: 2705752 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]